B
The startup develops a diagnostic and therapeutic system that utilizes patient blood samples to tailor immunosuppressive drug regimens for kidney transplant recipients. This approach enhances immunological management, reducing the risk of organ rejection and improving treatment outcomes for autoimmune diseases like arthritis.
Updated 3 months ago
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a diagnostic and therapeutic system that utilizes patient blood samples to tailor immunosuppressive drug regimens for kidney transplant recipients. This approach enhances immunological management, reducing the risk of organ rejection and improving treatment outcomes for autoimmune diseases like arthritis.